Page last updated on July 16, 2024
Zivo Bioscience, Inc. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-15 16:43:08 EDT.
Filings
10-K filed on 2024-03-15
Zivo Bioscience, Inc. filed a 10-K at 2024-03-15 16:43:08 EDT
Accession Number: 0001654954-24-003228
Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!
Item 1C. Cybersecurity.
Item 1C. Cybersecurity. Risk Management and Strategy Many aspects of our business are dependent upon our computer systems, devices, and networks to collect, process, and store data necessary to conduct many aspects of our business, including the analysis of our products, the maintenance of our intellectual property, the recording and reporting of commercial and financial information, and payroll. We rely on standard operating systems and software from established and reliable third parties to provide security including Microsoft 365, QuickBooks, and Paylocity. The Company does not have in-house information technology personnel. Management makes concerted efforts to select third-party software providers with a demonstrated track-record of effectively addressing cyber-security concerns. In event of a cyber-security incident, we would rely upon these providers. In light of the Company’s current size and relatively low cyber-risk profile, management believes that reliance upon experienced third-party providers is the most prudent and cost-effective course. To date, risks from cybersecurity threats or incidents have not materially affected our company. However, the sophistication of and risks from cybersecurity threats and incidents continues to increase, and the preventative actions that we have taken and continue to take to reduce the risk of cybersecurity threats and incidents and protect our systems and information may not successfully protect against all cybersecurity threats and incidents. For more information on how cybersecurity risk could materially affect our company’s business strategy, results of operations, or financial condition, please refer to Item 1A Risk Factors. Governance Our board stays informed on data privacy and information security issues and vulnerabilities that may be applicable to the Company. We outsource most aspects of our information technology management and these third party providers are available to address any cybersecurity issues that may arise.
Company Information
Name | Zivo Bioscience, Inc. |
CIK | 0001101026 |
SIC Description | Biological Products, (No Diagnostic Substances) |
Ticker | ZIVO - NasdaqZIVOW - Nasdaq |
Website | |
Category | Non-accelerated filer Smaller reporting company |
Fiscal Year End | December 30 |